1200 Pharma LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.1200pharma.com
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors
- First Posted Date
- 2021-11-02
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- 1200 Pharma, LLC
- Target Recruit Count
- 68
- Registration Number
- NCT05103046
- Locations
- 🇺🇸
UCLA - JCCC Clinical Research Unit, Los Angeles, California, United States
🇺🇸Torrance Memorial, Torrance, California, United States
🇺🇸Winship Institute of Emory University, Atlanta, Georgia, United States
First in Human Study of UCT-01-097 in Participants With Advanced Solid Tumors
Phase 1
Terminated
- Conditions
- Advanced Solid Tumor
- Interventions
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- 1200 Pharma, LLC
- Target Recruit Count
- 32
- Registration Number
- NCT04761601
- Locations
- 🇺🇸
UCLA - JCCC Clinical Research Unit, Los Angeles, California, United States
🇺🇸Torrance Memorial, Torrance, California, United States
🇺🇸Winship Institute of Emory University, Atlanta, Georgia, United States
News
No news found